Reportlinker finds all market research
reports published by official sources!
- Home
- Life Sciences
- Biotechnology
- Biopharmaceutical
- India
- The Indian Biogeneric Sector Brief
The Indian Biogeneric Sector Brief
- This 6-page industry report was published in October 2011.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Talk to Sam
+1 917 267 7886
Share
Biopharmaceutical Industry in India : Latest Downloads
Biopharmaceutical Business (biopharmaceutical, growth hormone, biogeneric) in Australia, India and Singapore
- Industry report
- June 2012
- 2 pages
... Of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights to manufacture, distribute ...
Biopharmaceutical Industry (biopharmaceutical, growth hormone) in Australia, Singapore and India
- Industry report
- June 2012
- 2 pages
... Such as rhuman growth hormone, rhuman insulin and gcsf. ______________________________________________________________________ Scigen limited arbn 101 318 852 suite 1, 13b narabang way, belrose, nsw 2085 ...
Biosimilar in India and China : Innovation and Technology Trends
- Industry report
- June 2012
- 20 pages
Enzyme Sector Analysis
3 months agoBiopharmaceutical Industry Brief
8 months agoBiopharmaceutical Sector Brief
8 months agoWorld Biopharmaceutical Industry Overview
8 months agoAntibody Market Brief
8 months agoBiopharmaceutical : Innovation And Technology ...
8 months agoBiopharmaceutical Market Brief
9 months agoKey Players
Biopharmaceutical In India And The United States : Indu...
12 months ago
More Reports:
Biopharmaceutical in Australia (8)
Company Reports
Biopharmaceutical Industry in India : Latest Reports
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016
- $ 2 500
- Industry report
- August 2012
- by Kalorama Information
What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies. Together, they have the potential to add billions ...
Analytical Tool - Antibodies and Peptides in Oncology
- $ 8 925
- Industry report
- April 2013
- by Bioseeker
"Analytical Tool - Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and ...
![Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017](https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1329.gif)
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017
- $ 4 650
- Industry report
- March 2013
- by MarketsandMarkets
Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently ...
More Reports:
Biopharmaceutical in China (12)
Reportlinker.com © Copyright 2013. All rights reserved.
